Embrace a healthier lifestyle todaytake the first step and find out if youre eligible for our program today
Fatty foods require more time and digestive effort to process, and when combined with semaglutide's gastric-slowing effects, they may sit uncomfortably in the stomach for extended periods
By modulating gene expression in response to stress, the peptide helps cells adapt more effectively to metabolic challenges
Stress triggers the release of cortisol, a hormone that encourages fat storageespecially in the belly area

Key safety monitoring parameters include: Baseline and periodic assessment of nutritional status (complete blood count, comprehensive metabolic panel, vitamin levels, albumin) Renal function monitoring, particularly during dose escalation, due to risk of acute kidney injury from dehydration Evaluation for gastrointestinal symptoms and differentiation from surgical complications Monitoring for gallbladder disease, which may be increased with weight loss and semaglutide use Assessment of medication adherence and injection technique Eye examination in patients with diabetes due to potential risk of diabetic retinopathy progression with rapid glycemic improvement Regular follow-up with both bariatric surgery and endocrinology or obesity medicine teams when possible Patients should be counseled to report severe or persistent nausea, vomiting, abdominal pain, or inability to maintain adequate hydration or nutrition, as these may warrant dose adjustment, temporary discontinuation, or further evaluation for surgical complications
